Needham & Co Upgrades Alnylam Pharmaceuticals (ALNY) to Hold Based on Valuation and Pipeline Progress
Tweet Send to a Friend
Needham & Co upgrades Alnylam Pharmaceuticals (Nasdaq: ALNY) from Underperform to Hold.
Needham analyst says, "In a quarterly conference ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "In a quarterly conference ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
